GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Other Long-Term Liabilities

Organon Pharma Indonesia PT (ISX:SCPI) Other Long-Term Liabilities : Rp0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Other Long-Term Liabilities?

Organon Pharma Indonesia PT's other long-term liabilities for the quarter that ended in . 20 was Rp0.00 Mil.


Organon Pharma Indonesia PT Other Long-Term Liabilities Historical Data

The historical data trend for Organon Pharma Indonesia PT's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Other Long-Term Liabilities Chart

Organon Pharma Indonesia PT Annual Data
Trend
Other Long-Term Liabilities

Organon Pharma Indonesia PT Quarterly Data
Other Long-Term Liabilities

Organon Pharma Indonesia PT Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Organon Pharma Indonesia PT Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines